ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q2SCImago #8,541Hybrid

Cardiovascular Revascularization Medicine

Identifier (ISSN):1553-8389(Print)/1878-0938(Online)
•
Publisher:Elsevier
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
2.3↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Cardiovascular Revascularization Medicine

WoS Q3
12231.720231.620241.920252.32026
Annual Impact Factor Metric
Current (2026):2.3
Scopus SJR & RankScopus Q2
0.679
#8,541

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
50

50 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate6.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
211articles/year
18.46% Gold OA•89.51% Original Research

Aims & Scope

Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.

Topics Covered (Recognized by AI)
MedicineInternal MedicineCardiologySurgeryPsychologyPsychiatryRadiologyBiologyPathologyPhysics
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q3
Rank125/237
IndexESCI
JCIESCI2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q2
Rank113/237
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.3
Articles / Year162
Total Citations18
2025
IF1.9
Articles / Year272
Total Citations400
2024
IF1.6
Articles / Year465
Total Citations773
2023
IF1.7
Articles / Year562
Total Citations1,038
2022
IF—
Articles / Year574
Total Citations1,265

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,541Scopus Q2SCImago Profile
Scopus Coverage:2005-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.679

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.24

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,987 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,263
3-Year Documents996
Citable Documents648

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate18.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ2
Medicine (miscellaneous)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区CARDIAC & CARDIOVASCULAR SYSTEMS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cardiovascular Revascularization Medicine (ISSN: 1553-8389) is a peer-reviewed international scholarly journal in the field of CARDIAC & CARDIOVASCULAR SYSTEMS, published by Elsevier in Netherlands. The periodical holds a Journal Impact Factor (JIF) of 2.30, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.679 (Q2), an H-index of 50.

The journal enforces rigorous peer evaluation with an annual output of approximately 211 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,987 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4891670a-b724-42da-9c4c-2cdb9b50d773
Database Updated: 2026-10-16